ESR1 and breast carcinoma: Nguyen et al. investigated 10 patients with ER+, PR+, and HER2- breast cancer patients with 68Ga-DOTATATE and 18F-FDG PET/CT and compared the findings with conventional imaging (bone scan and diagnostic CT) [73].